Retatrutide

Retatrutide 10mg

$119.00SOLD OUT

High-purity Retatrutide (10mg per vial) for advanced metabolic research. Triple agonist targeting GLP-1, GIP, and glucagon receptors. Supplied as a lyophilized powder in a sealed, batch-tested vial.

Technical Specifications

PURITY
≥99% (HPLC/MS)
FORM
Lyophilized Powder
VIAL AMOUNT
10mg
CLASSIFICATION
Synthetic Peptide (RUO)
RESEARCH USE ONLY

This product is intended strictly for in-vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. By purchasing, you confirm you are a qualified researcher or institution.

  • Ships within 24 hours (Mon–Fri) · US domestic only
  • Certificate of Analysis available on request
  • Sealed, batch-tested vial with lot number

Product Description

Retatrutide is a novel synthetic peptide engineered as a triple receptor agonist, simultaneously targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCGR) receptors. This unique tri-agonist profile makes it a compelling subject for metabolic pathway research.

Each 10mg vial is produced under strict laboratory conditions and verified at ≥99% purity via high-performance liquid chromatography (HPLC) and mass spectrometry (MS). A batch-specific Certificate of Analysis is available with every order.

Handling & Storage

  • Store lyophilized vials at -20°C, protected from light.
  • Once reconstituted, store at 2–8°C and use within research protocol timelines.
  • Avoid repeated freeze-thaw cycles.
  • Reconstitute with bacteriostatic water for laboratory applications.